Mirae Asset Global Investments Co., Ltd. Vera Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,110 shares of VERA stock, worth $58,658. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,110
Previous 1,983
6.4%
Holding current value
$58,658
Previous $87,000
2.3%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$156 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$122 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$92.8 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$82.3 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$82 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $752M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...